Repositori URV

Identificador: imarina:9286876

Handle: https://hdl.handle.net/20.500.11797/imarina9286876

Autors:
Fanelli, GiuseppeMota, Nina RothSalas-Salvado, JordiBullo, MonicaFernandez-Aranda, FernandoCamacho-Barcia, LuciaTesta, GiuliaJimenez-Murcia, SusanaBertaina-Anglade, ValerieFranke, BarbaraPoelmans, Geertvan Gils, VeerleJansen, Willemijn JVos, Stephanie J BWimberley, TheresaDalsgaard, SorenBarta, CsabaSerretti, AlessandroFabbri, ChiaraBralten, Janita

Resum:
Clinical and genomic studies have shown an overlap between neuropsychiatric disorders and insulin resistance (IR)-related somatic conditions, including obesity, type 2 diabetes, and cardiovascular diseases. Impaired cognition is often observed among neuropsychiatric disorders, where multiple cognitive domains may be affected. In this review, we aimed to summarise previous evidence on the relationship between IR-related diseases/traits and cognitive performance in the large UK Biobank study cohort. Electronic searches were conducted on PubMed, Scopus, and Web of Science until April 2022. Eighteen articles met the inclusion criteria and were qualitatively reviewed. Overall, there is substantial evidence for an association between IR-related cardio-metabolic diseases/traits and worse performance on various cognitive domains, which is largely independent of possible confoundings. The most consistent findings referred to IR-related associations with poorer verbal and numerical reasoning ability, as well as slower processing speed. The observed associations might be mediated by alterations in immune-inflammation, brain integrity/connectivity, and/or comorbid somatic or psychiatric diseases/traits. Our findings provide impetus for further research into the underlying neurobiology and possible new therapeutic targets.